SongC, DufourVL, CideciyanAV, et al.Dose range finding studies with two RPGR transgenes in a canine model of X-linked retinitis pigmentosa treated with subretinal gene therapy. Hum Gene Ther, 2020; 31:743–755.
2.
FrederickA, SullivanJ, LiuL, et al.Engineered capsids for efficient gene delivery to the retina and cornea. Hum Gene Ther, 2020; 31:756–774.
3.
RossM, ObolenskyA, AverbukhE, et al.Evaluation of photoreceptor transduction efficacy of capsid- modified AAV vectors following intravitreal and subretinal delivery in sheep. Hum Gene Ther, 2020; 31:719–729.
4.
OrlansHO, BarnardAR, PatrícioMI, et al.Effect of AAV-mediated rhodopsin gene augmentation on retinal degeneration caused by the dominant P23H rhodopsin mutation. Hum Gene Ther, 2020; 31:730–742.
5.
kleine HolthausS-M, AristorenaM, MaswoodR, et al.Gene therapy targeting the inner retina rescues the retinal phenotype in a mouse model of CLN3 Batten disease. Hum Gene Ther, 2020; 31:709–718.
